Food for thought... can case study approaches speed implementation of the NRC report: "Toxicity testing in the 21st century: A vision and a strategy?"

Altex

Volumn 28, Issue 3, 2011, Pages 175-182

  Andersen, Melvin E ^a   Clewell III, Harvey J ^a   Carmichael, Paul L ^b   Boekelheide, Kim ^c  

^a HAMNER INSTITUTES FOR HEALTH SCIENCES   (United States)

^b UNILEVER RESEARCH   (United Kingdom)

^c BROWN UNIVERSITY   (United States)

Author keywords

Case study approach; Toxicity pathway; Toxicity testing

Indexed keywords

ESTROGEN RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA;

ARTICLE; DNA DAMAGE; DNA SEQUENCE; HUMAN; IN VITRO STUDY; LIVER CELL; METABOLOMICS; NONHUMAN; PRACTICE GUIDELINE; PROTEOMICS; RISK ASSESSMENT; STEM CELL; TOXICITY TESTING; TRANSCRIPTOMICS; ANIMAL; ANIMAL TESTING ALTERNATIVE; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; METABOLISM; METHODOLOGY; REPRODUCIBILITY;

ANIMAL TESTING ALTERNATIVES; ANIMALS; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; METABOLIC NETWORKS AND PATHWAYS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; TOXICITY TESTS;

EID: 80053490835     PISSN: 09467785     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (64)

1. Aldridge, B. B., Burke, J. M., Lauffenburger, D. A., and Sorger, P. K. (2006). Physicochemical modelling of cell signalling pathways. Nat. Cell Biol. 8, 1195-1203. (Pubitemid 44660581)
2. Alon, U. (2007). Network motifs: theory and experimental approaches. Nat. Rev. Genet. 8, 450-461.
3. Andersen, M. E., Clewell, H. J., 3rd, Gargas, M. L., et al. (1987). A physiologically based pharmacokinetics and the risk assessment process for methylene chloride. Toxicol. Appl. Pharmacol. 87, 185-205. (Pubitemid 17019104)
4. st century: bringing the vision to life. Toxicol. Sci. 107, 324-330.
5. st century: Moving from discussion to action. Toxicol. Sci. 117, 17-24
6. Batchelor, E., Mock, C. S., Bhan, I., et al. (2008). Recurrent initiation: A mechanism for triggering p53 pulses in response to DNA damage. Mol. Cell 30, 277-289. (Pubitemid 351615316)
7. Batchelor, E., Loewer, A., and Lahav, G. (2009). The ups and downs of p53: understanding protein dynamics in single cells. Nat. Rev. Cancer 9, 371-377.
8. Benchimol, S., Pim, D., and Crawford, L. (1982). Radioimmunoassay of the cellular protein p53 in mouse and human cell lines. Embo J. 1, 1055-1062.
9. st century: defining new risk assessment approaches based on perturbation of intracellular toxicity pathways. PLoS One 6, e20887.
10. Boekelheide, K., and Andersen, M. E. (2010). A mechanistic redefinition of adverse effects - a key step in the toxicity testing paradigm shift. ALTEX 27, 243-252.
11. st century: using the new toxicity testing paradigm to create a taxonomy of adverse effects. Toxicol. Sci. 114, 20-24.
12. Boobis, A. R., Cohen, S. M., Dellarco, V., et al. (2006). IPCS framework for analyzing the relevance of a cancer mode of action for humans. Crit. Rev. Toxicol. 36, 781-792. (Pubitemid 44800328)
13. Boobis, A. R., Doe, J. E., Heinrich-Hirsch, B., et al. (2008). IPCS framework for analyzing the relevance of a noncancer mode of action for humans. Crit. Rev. Toxicol. 38, 87-96. (Pubitemid 351225507)
14. Bromberg, K. D., Iyengar, R., and He, J. C. (2008a). Regulation of neurite outgrowth by G(i/o) signaling pathways. Front. Biosci. 13, 4544-4557. (Pubitemid 351589181)
15. Bromberg, K. D., Ma'ayan, A., Neves, S. R., and Iyengar, R. (2008b). Design logic of a cannabinoid receptor signaling network that triggers neurite outgrowth. Science 320, 903-909. (Pubitemid 351929582)
16. Bryce, S. M., Avlasevich, S. L., Bemis, J. C., et al. (2008). Interlaboratory evaluation of a flow cytometric, high content in vitro micronucleus assay. Mutat. Res. 650, 181-195.
17. Clewell, H. J., Tan, Y. M., Campbell, J. L., and Andersen, M. E. (2008). Quantitative interpretation of human biomonitoring data. Toxicol. Appl. Pharmacol. 231, 122-133.
18. Collins, F. S., Gray, G. M., and Bucher, J. R. (2008). Toxicology. Transforming environmental health protection. Science 319, 906-907. (Pubitemid 351263750)
19. di Bernardo, D., Thompson, M. J., Gardner, T. S., et al. (2005). Chemogenomic profiling on a genome-wide scale using reverse-engineered gene networks. Nat. Biotechnol. 23, 377-383. (Pubitemid 41094431)
20. st century assessment of "Endocrine disruption". ALTEX 27, 264-278.
21. Fertuck, K. C., Eckel, J. E., Gennings, C., and Zacharewski, T. R. (2003). Identification of temporal patterns of gene expression in the uteri of immature, ovariectomized mice following exposure to ethynylestradiol. Physiol. Genomics 15, 127-141. (Pubitemid 38089559)
22. Gibson, G. G., and Rostami-Hodjegan, A. (2007). Modelling and simulation in prediction of human xenobiotic absorption, distribution, metabolism and excretion (ADME): in vitro-in vivo extrapolations (IVIVE). Xenobiotica 37, 1013-1014
23. Hartung, T. (2008). Food for thought ... on alternative methods for cosmetics safety testing. ALTEX 25, 147-162.
24. Hartung, T., and Koëter, H. (2008). Food for thought ... on food safety testing. ALTEX 25, 259-264
25. Hartung, T., and Leist, M. (2008). Food for thought ... on the evolution of toxicology and the phasing out of animal testing. ALTEX 25, 91-102.
26. Hartung, T., Blaauboer, B., and Leist, M. (2009). Food for thought ... on education in alternative methods in toxicology. ALTEX 26, 255-263.
27. st century? ALTEX 27, 253-263.
28. Hartung, T. (2010b). Food for thought ... on alternative methods for nanoparticle safety testing. ALTEX 27, 87-95.
29. Hartung, T., and McBride, M. (2011). Food for thought ... on mapping the human toxome. ALTEX 28, 83-93.
30. Hoffmann, S., and Hartung, T. (2006). Toward an evidence-based toxicology. Hum. Exp. Toxicol. 25, 497-513. (Pubitemid 44409040)
31. Inglese, J., Auld, D. S., Jadhav, A., et al. (2006). Quantitative high-throughput screening: a titration-based approach that efficiently identifies biological activities in large chemical libraries. Proc. Natl. Acad. Sci. USA 103, 11473-11478. (Pubitemid 44182476)
32. Jaworska, J., and Hoffmann, S. (2010). Integrated Testing Strategy (ITS) - Opportunities to better use existing data and guide future testing in toxicology. ALTEX 27, 231-242.
33. Julien, E., Boobis, A. R., and Olin, S. S. (2009). The key events dose-response framework: a cross-disciplinary mode-of-action based approach to examining dose-response and thresholds. Crit. Rev. Food Sci. Nutr. 49, 682-689.
34. st century: Implications for human health risk assessment. Risk Anal. 29, 474-479.
35. st century: A vision and a strategy. J. Toxicol. Environ. Health B Crit. Rev. 13, 51-138.
36. Krewski, D., Westphal, M., Al-Zoughool, M., et al. (2011). New directions in toxicity testing. Annu. Rev. Public Health 32, 161-178.
37. Kuegler, P. B., Zimmer, B., Waldmann, T., et al. (2010). Markers of murine embryonic and neural stem cells, neurons and astrocytes: reference points for developmental neurotoxicity testing. ALTEX 27, 17-42.
38. Kwekel, J. C., Burgoon, L. D., Burt, J. W., et al. (2005). A cross-species analysis of the rodent uterotrophic program: elucidation of conserved responses and targets of estrogen signaling. Physiol. Genomics 23, 327-342. (Pubitemid 44437969)
39. Lahav, G., Rosenfeld, N., Sigal, A., et al. (2004). Dynamics of the p53-Mdm2 feedback loop in individual cells. Nat. Genet. 36, 147-150. (Pubitemid 38174372)
40. Landers, J. P., and Spelsberg, T. C. (1992). New concepts in steroid hormone action: transcription factors, proto-oncogenes, and the cascade model for steroid regulation of gene expression. Crit. Rev. Eukaryot. Gene Expr. 2, 19-63.
41. Leist, M., Bremer, S., Brundin, P., et al. (2008). The biological and ethical basis of the use of human embryonic stem cells for in vitro test systems or cell therapy. ALTEX 25, 163-190.
42. Loewer, A., Batchelor, E., Gaglia, G., and Lahav, G. (2010). Basal dynamics of p53 reveal transcriptionally attenuated pulses in cycling cells. Cell 142, 89-100.
43. Lutz, W. K., and Lutz, R. W. (2009). Statistical model to estimate a threshold dose and its confidence limits for the analysis of sublinear dose-response relationships, exemplified for mutagenicity data. Mutat. Res. 678, 118-122.
44. Melas, I. N., Mitsos, A., Messinis, D. E., et al. (2011). Combined logical and data-driven models for linking signalling pathways to cellular response. BMC Syst. Biol. 5, 107.
45. Naciff, J. M., Khambatta, Z. S., Thomason, R. G., et al. (2009). The genomic response of a human uterine endometrial adenocarcinoma cell line to 17alpha-ethynyl estradiol. Toxicol. Sci. 107, 40-55.
46. NRC (1983). Risk assessment in the federal government: managing the process. Washington, D.C: The National Academy Press.
47. st century: A vision and a strategy. Washington, DC: The National Academies Press.
48. Ramsey, J. C., and Andersen, M. E. (1984). A physiologically based description of the inhalation pharmacokinetics of styrene in rats and humans. Toxicol. Appl. Pharmacol. 73, 159-175. (Pubitemid 14131618)
49. Rotroff, D. M., Beam, A. L., Dix, D. J., et al. (2010). Xenobiotic-metabolizing enzyme and transporter gene expression in primary cultures of human hepatocytes modulated by ToxCast chemicals. J. Toxicol. Environ. Health B Crit. Rev. 13, 329-346.
50. 4). ALTEX 26, 187-208.
51. Sachs, K., Gifford, D., Jaakkola, T., et al. (2002). Bayesian network approach to cell signaling pathway modeling. Sci. STKE 2002, pe38.
52. Samaga, R., Saez-Rodriguez, J., Alexopoulos, L. G., et al. (2009). The logic of EGFR/ErbB signaling: theoretical properties and analysis of high-throughput data. PLoS Comput. Biol. 5, e1000438.
53. Shen, C., Huang, Y., Liu, Y., et al. (2011). A modulated empirical Bayes model for identifying topological and temporal estrogen receptor alpha regulatory networks in breast cancer. BMC Syst. Biol. 5, 67.
54. Shiran, M. R., Proctor, N. J., Howgate, E. M., et al. (2006). Prediction of metabolic drug clearance in humans: in vitro-in vivo extrapolation vs allometric scaling. Xenobiotica 36, 567-580. (Pubitemid 44174445)
55. Simmons, S. O., Fan, C. Y., and Ramabhadran, R. (2009). Cellular stress response pathway system as a sentinel ensemble in toxicological screening. Toxicol. Sci. 111, 202-225.
56. Slikker, W., Jr, Andersen, M. E., Bogdanffy, M. S., et al. (2004a). Dose-dependent transitions in mechanisms of toxicity: case studies. Toxicol. Appl. Pharmacol. 201, 226-294. (Pubitemid 39593626)
57. Slikker, W., Jr, Andersen, M. E., Bogdanffy, M. S., et al. (2004b). Dose-dependent transitions in mechanisms of toxicity. Toxicol. Appl. Pharmacol. 201, 203-225. (Pubitemid 39593625)
58. Sonich-Mullin, C., Fielder, R., Wiltse, J., et al. (2001). IPCS conceptual framework for evaluating a mode of action for chemical carcinogenesis. Regul. Toxicol. Pharmacol. 34, 146-152. (Pubitemid 33022326)
59. Sun, B., Daniels, K., Ross, S., et al. (2011). Dose-response evaluation of p53 and H2AX DNA damage response by methyl methanesulfonate, etoposide, and quercetin. The Toxicologist, 24.
60. van Attikum, H., and Gasser, S. M. (2009). Crosstalk between histone modifications during the DNA damage response. Trends Cell Biol. 19, 207-217.
61. Wang, Y., Yao, H. L., Cui, C. B., et al. (2010). Paracrine signals from mesenchymal cell populations govern the expansion and differentiation of human hepatic stem cells to adult liver fates. Hepatology 52, 1443-1454.
62. Woods, C. G., Yarborough, K. M., Pluta, L. J., et al. (2011). Constructing a PPARa-mediated transcriptional network in primary human and rat heaptocytes. The Toxicologist, 78.
63. Woolf, P. J., Prudhomme, W., Daheron, L., et al. (2005). Bayesian analysis of signaling networks governing embryonic stem cell fate decisions. Bioinformatics 21, 741-753. (Pubitemid 40439410)
64. Zorina, Y., Iyengar, R., and Bromberg, K. D. (2010). Cannabinoid 1 receptor and interleukin-6 receptor together induce integration of protein kinase and transcription factor signaling to trigger neurite outgrowth. J. Biol. Chem. 285, 1358-1370.